why choose us

First received: October 30, 2023

Clinical Trial: A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Thrombosis

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered SRSD107

Brief Summary: The primary aim of this study is to evaluate safety and tolerability data when SRSD107 is administered as single SC injections to healthy participants.This information, along with PK/PD data, will help establish the appropriate doses and dosing regimen for future studies in patients.

Read more